IMPLANT SITE INFLAMMATION

This adverse event was reported 293 times

These drugs are most commonly taken by patients reporting IMPLANT SITE INFLAMMATION:

# Drug Count
0 ETONOGESTREL 127
1 GABAPENTIN 14
2 ASPIRIN 13
3 ASPIRIN 325 MG 13
4 ASPIRIN 81 MG 13
5 BACLOFEN 13
6 PANTOPRAZOLE 12
7 ADALIMUMAB 11
8 ALLOPURINOL 10
9 IBUPFROFEN 9
See all common drugs associated with IMPLANT SITE INFLAMMATION

IMPLANT SITE INFLAMMATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HISTRELIN ACETATE 2 0.0023
1 ETONOGESTREL 127 0.0022
2 PEPPERMINT OIL 1 0.0009
3 TRABECTEDIN 2 0.0009
4 VANCOMYCIN HYDROCHLORIDE 7 0.0008
5 NARATRIPTAN 1 0.0007
6 BACLOFEN INJECTION 2 0.0006
7 ESTRIOL 1 0.0005
8 AMOXICILLIN AND CLAVULANATE POTASSIUM 2 0.0004
9 KETOROLAC TROMETHAMINE 2 0.0004
See all drugs enriched for association with IMPLANT SITE INFLAMMATION

IMPLANT SITE INFLAMMATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 1 0.0005
1 Progestin [EPC] 128 0.0004
2 Antiparasitic [EPC] 1 0.0002
3 Androgen [EPC] 6 0.0002
4 Pediculicide [EPC] 1 0.0002
5 Osmotic Diuretic [EPC] 1 0.0002
6 gamma-Aminobutyric Acid-ergic Agonist [EPC] 14 0.0002
7 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1 0.0001
8 Provitamin D2 Compound [EPC] 4 0.0001
9 Glycopeptide Antibacterial [EPC] 7 0.0001
See all drug classes enriched for association with IMPLANT SITE INFLAMMATION